Cargando…

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis

Fibrosis across different organs and tissues is likely to share common pathophysiological mechanisms and pathways. Recently, a polymorphism (rs12979860) near the interferon lambda gene (IFNL3) was shown to be associated with fibrosis in liver across multiple disease etiologies. We determined whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metwally, Mayada, Thabet, Khaled, Bayoumi, Ali, Nikpour, Mandana, Stevens, Wendy, Sahhar, Joanne, Zochling, Jane, Roddy, Janet, Tymms, Kathleen, Strickland, Gemma, Lester, Susan, Rischmueller, Maureen, Ngian, Gene-Siew, Walker, Jennifer, Hissaria, Pravin, Shaker, Olfat, Liddle, Christopher, Manolios, Nicholas, Beretta, Lorenzo, Proudman, Susanna, George, Jacob, Eslam, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795812/ https://www.ncbi.nlm.nih.gov/pubmed/31619697 http://dx.doi.org/10.1038/s41598-019-50709-9

Ejemplares similares

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
por: Thakkar, Vivek, et al.
Publicado: (2012)

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
por: Nikpour, Mandana, et al.
Publicado: (2011)

Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
por: Morrisroe, Kathleen, et al.
Publicado: (2022)

Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis
por: Moxey, Jayne, et al.
Publicado: (2019)

Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study
por: Esposito, James, et al.
Publicado: (2016)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
por: Thakkar, Vivek, et al.
Publicado: (2013)

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study
por: Osthoff, Michael, et al.
Publicado: (2014)

Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
por: Hao, Yanjie, et al.
Publicado: (2015)

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3
por: Zochling, Jane, et al.
Publicado: (2014)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis
por: Massolino, Rose I, et al.
Publicado: (2018)

Determinants of left ventricular structure, filling and long axis function in systemic sclerosis
por: Peverill, Roger E., et al.
Publicado: (2021)

Cardiovascular disease in systemic sclerosis - an emerging association?
por: Ngian, Gene-Siew, et al.
Publicado: (2011)

IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection
por: O'Connor, K S, et al.
Publicado: (2016)

Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C
por: Amanzada, Ahmad, et al.
Publicado: (2015)

IFNL4 and IFNL3 Associated Polymorphisms Strongly Influence the Spontaneous IFN-Alpha Receptor-1 Expression in HCV-Infected Patients
por: Bordi, Licia, et al.
Publicado: (2015)

Ant Lion Optimization algorithm for kidney exchanges
por: Hamouda, Eslam, et al.
Publicado: (2018)

Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies
por: Day, Jessica, et al.
Publicado: (2020)

IFNL4 genetic variant can predispose to COVID-19
por: Saponi-Cortes, Jose Maria R., et al.
Publicado: (2021)

Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations
por: Angelim, Carolina Cabral, et al.
Publicado: (2023)

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
por: Morrisroe, Kathleen, et al.
Publicado: (2016)

Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.
por: Jeannin, Severine, et al.
Publicado: (2015)

Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.
por: Jeannin, Severine, et al.
Publicado: (2015)

COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes
por: Mihm, Sabine
Publicado: (2020)

Hepatic IFNL4 Gene Activation in Hepatocellular Carcinoma Patients with Regard to Etiology
por: Huschka, Henriette, et al.
Publicado: (2021)

Antiviral Effect of pIFNLs against PEDV and VSV Infection in Different Cells
por: Chen, Jing, et al.
Publicado: (2022)

Interferon-λ(4) (IFNL4) Transcript Expression in Human Liver Tissue Samples
por: Amanzada, Ahmad, et al.
Publicado: (2013)

IFNL4 and donor selection for matched unrelated donor haematopoietic stem-cell transplantation
por: Westervelt, Peter
Publicado: (2020)

Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis
por: Lin, Emily, et al.
Publicado: (2019)

Detection of allele specific differences in IFNL3 (IL28B) mRNA expression
por: Knapp, Susanne, et al.
Publicado: (2014)

Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C
por: Aiken, Taylor, et al.
Publicado: (2016)

IFNL4 polymorphism as a predictor of chronic hepatitis C treatment efficiency in Ukrainian patients
por: Kucherenko, A. M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_369mbj134jqrps4vmocm793si4